TrianglePUBLICATIONS · 36753699
Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2023 May 10
- First author
- Wang Y
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Wang Y
- type
- Author
- name
- Jain P
- type
- Author
- name
- Locke FL
- type
- Author
- name
- Maurer MJ
- type
- Author
- name
- Frank MJ
- type
- Author
- name
- Munoz JL
- type
- Author
- name
- Dahiya S
- type
- Author
- name
- Beitinjaneh AM
- type
- Author
- name
- Jacobs MT
- type
- Author
- name
- Mcguirk JP
- type
- Author
- name
- Vose JM
- type
- Author
- name
- Goy A
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Wang Y
- type
- Author
- name
- Jain P
- type
- Author
- name
- Locke FL
- type
- Author
- name
- Maurer MJ
- type
- Author
- name
- Frank MJ
- type
- Author
- name
- Munoz JL
- type
- Author
- name
- Dahiya S
- type
- Author
- name
- Beitinjaneh AM
- type
- Author
- name
- Jacobs MT
- type
- Author
- name
- Mcguirk JP
- type
- Author
- name
- Vose JM
- type
- Author
- name
- Goy A
- type
- Author
- bibliography ids
- nci-bib-19e60fcdc453d70ff022634d
- book metadata
- content sha256
- 86569cc9f9320af972ab0103ab379e7cd54723482ab7c9f764ee779e16a362d1
- document type
- citation
- dois
- 10.1200/JCO.22.01797
- electronic publication date
- display
- 2023 Feb 8
- precision
- day
- year
- 2023
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:36753699
- immutable id
- pubmed:36753699@86569cc9f9320af972ab0103ab379e7cd54723482ab7c9f764ee779e16a362d1
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 14
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2594-2606
- volume
- 41
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 36753699
- provenance
- batch id
- d370e99271168e8a8a13
- provider
- NCBI PubMed ESummary
- record sha256
- 1a881a30c516130fe765aa36cd9777771195ee77bb8dbe91d95ce586697d5cf9
- response sha256
- f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
- retrieved at
- 2026-09-09T23:48:13.005737+00:00
- publication date
- display
- 2023 May 10
- precision
- day
- year
- 2023
- publication types
- Journal Article
- Research Support, N.I.H., Extramural
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium.
Preserved source evidence · Not medical advice